We recently published a list of 8 Best Low Volatility Stocks To Buy Right Now. In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE:TMO) stands against other best low volatility stocks to buy right now.
The market has shown strong performance overall, with the S&P 500 up nearly 26% year to date. However, in the past thirty days, it has experienced a slight decline of 1%. A notable sell-off occurred between December 17 and 19, which contributed to some volatility. Since then, the market has been fluctuating, with prices rising and falling as investors continue to navigate the uncertainty.
In a CNBC interview, Alan Rechtschaffen, Senior Portfolio Manager at UBS Global Wealth, stressed that he maintains a positive outlook on market growth, emphasizing that the current market sell-off is driven by a lack of faith rather than fundamental issues. He noted that the positivity surrounding the market will improve as President Trump’s policies take effect.
Rechtschaffen acknowledged concerns over high interest rates and high debt levels but argued that the Fed’s goal of lowering rates, combined with efforts to reduce spending and increase efficiency, will lead to high growth. He is particularly optimistic about sectors like technology, utilities, and financials, which he believes will benefit from a focus on new energy sources and deregulation. Although valuations are higher than usual, Rechtschaffen believes that with the right efficiencies in place, the market could see a 10% rise, offering opportunities for investors willing to take risks in this promising period.
The path of rate cuts in 2025 is creating uncertainty for Wall Street as the Fed’s outlook shifted last week, now forecasting two cuts instead of four. The possibility of a rate hike has not been ruled out if inflation re-accelerates. San Francisco Fed President Mary Daly told Yahoo Finance’s Brian Sozzi that adjustments could be made depending on data, but she doesn’t see inflationary pressures at the moment. However, she isn’t ruling out anything.
On Yahoo Finance’s Catalysts, Max Wasserman of Miramar Capital said that he believes the economy is stronger than anticipated, with GDP growth around 3% and inflation at 2.7%, which reduces the need for aggressive rate cuts. He also suggested that a rate hike could become more likely in the second half of 2025 if inflation remains persistent.
Wasserman advised a more cautious approach in portfolio management, favoring de-risking strategies, such as taking profits from top-performing stocks and focusing on dividend stocks. He also recommended staying short-term on bonds, as rising interest rates could pressure longer-duration bonds. Additionally, he expressed concerns about potential inflationary policies from the incoming administration, such as changes to immigration or tariffs, which could further strain the economy and complicate the Fed’s path forward.
For this article, we used the Yahoo Finance stocks screener to identify 30 companies with the largest market cap and a 5-year beta (monthly) between 0.2 and 0.8. Next, we narrowed our list to 8 stocks most widely held by institutional investors. The 8 best low-risk stocks to buy are listed in ascending order of their hedge fund sentiment.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
Is Thermo Fisher Scientific Inc. (NYSE:TMO) the Best Low Volatility Stock To Buy Right Now?
A workstation in a research lab stocked with laboratory products and services.
5-year Beta (Monthly): 0.79
Number of Hedge Fund Holders: 98
Thermo Fisher Scientific Inc. (NYSE:TMO) provides a wide range of products and services for life sciences, diagnostics, and laboratory research. It offers tools for biological research, drug production, disease diagnosis, and clinical testing. Scotiabank maintains a positive long-term outlook for the life science tools sector, considering it “bullish,” and regards three stocks, including Thermo Fisher, as “some of the highest-quality stocks to own.”
However, in the short term, the firm adopts a more neutral stance on these large-cap stocks due to ongoing uncertainties in key markets, particularly biopharma, and China, as well as potential political risks heading into 2024, according to the analyst. On 23 December, as reported by TipRanks, Scotiabank started coverage of Thermo Fisher (NYSE:TMO) with a Sector Perform rating and a price target of $605, while BofA has a price target of $660 on the stock and a Buy rating as reported on December 13.
Thermo Fisher’s (NYSE:TMO) acquisitions are delivering strong results. The company’s recent acquisition of Olink Holdings for $3.1 billion, which was finalized in the third quarter, is helping to improve its capabilities in the rapidly growing proteomics market. The acquisition is expected to deliver synergies, with the company projecting $125 million in adjusted operating income synergies by the fifth year.
The Binding Site, which is now the company’s protein diagnostics business and was acquired in 2023, continues to perform well. In the third quarter, the company secured an IVDR claim extension in the European Union for its Optilite Freelite Mx, enabling it to assist in diagnosing neurological diseases like multiple sclerosis.
Overall, TMO ranks 4th on our list of best low volatility stocks to buy right now. While we acknowledge the potential of TMO as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TMO but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
